Thyroglobulin (Tg): The Lab That Helps Track Thyroid Cancer After Surgery
Written by John P. Sabra, MD FACS
Updated September 2026
Educational only. This article is not medical advice. Always consult your physician about your individual situation.
For patients who have had thyroid cancer surgery, one of the important blood tests to track afterward is thyroglobulin. After a total thyroidectomy, thyroglobulin should be undetectable. Any measurable level indicates that some thyroid cells (cancerous or benign) remain somewhere in the body. Used correctly, this single lab can detect a recurrence months or years before any imaging would, and it is the foundation of the surveillance program for differentiated thyroid cancer.
Thyroglobulin is a large protein produced exclusively by thyroid follicular cells. Normal thyroid tissue produces it. Differentiated thyroid cancer (papillary, follicular, Hurthle cell) usually continues to produce it. After a complete total thyroidectomy and, when indicated, radioactive iodine therapy (RAI), all thyroid tissue, both normal and cancerous, should be eliminated. The thyroglobulin level in the blood should fall toward zero. If it does not, or if it rises later, the explanation is that some thyroid cells remain.
The power of thyroglobulin as a surveillance marker comes from this specificity. No other cells in the body produce thyroglobulin. The test is essentially binary in interpretation: zero means no thyroid cells anywhere. Detectable means thyroid cells exist somewhere. The size of the number tells you how much tissue is present, and the trend over time tells you whether it is growing.
When Thyroglobulin Is Useful and When It Is Not
Thyroglobulin is most useful in patients who have had total thyroidectomy for differentiated thyroid cancer. The expectation in this group is that the level should be very low or undetectable. Any rise prompts attention.
-
After total thyroidectomy plus RAI: Thyroglobulin should be undetectable or extremely low. Reliable as a recurrence marker.
-
After total thyroidectomy without RAI: Thyroglobulin may be detectable initially from residual normal thyroid tissue. It should decline over time. A stable low level is acceptable; a rising level prompts investigation.
-
After lobectomy alone: Thyroglobulin is produced by the remaining thyroid lobe and is not a reliable marker for cancer recurrence. Surveillance in these patients relies on ultrasound rather than thyroglobulin.
-
For medullary thyroid cancer: Thyroglobulin is not the marker. Calcitonin is. Medullary thyroid cancer arises from a different cell population that does not produce thyroglobulin.
⚕ Clinical note: The interpretation of thyroglobulin depends on the entire clinical picture, not the number in isolation. A thyroglobulin of 0.4 ng/mL after total thyroidectomy and RAI means something different from a 0.4 ng/mL after total thyroidectomy alone. The trend over time matters more than any single value.
Thyroglobulin Antibodies: The Critical Companion Test
Every thyroglobulin test should be paired with a thyroglobulin antibody (TgAb) test. Approximately 20 to 25% of thyroid cancer patients have antibodies to thyroglobulin in their blood. These antibodies interfere with the thyroglobulin measurement and can produce falsely low values. A patient with detectable TgAb cannot have their thyroglobulin interpreted by the same standard rules.
In patients with TgAb interference, the antibody level itself becomes a surrogate marker. A rising TgAb over time can indicate recurrent disease even when measured thyroglobulin appears stable. A falling TgAb over time is a favorable sign. This is one reason both tests are always ordered together, and why a thyroid cancer patient who has had only thyroglobulin checked without thyroglobulin antibody should proceed to have both done.
Stimulated vs. Unstimulated Thyroglobulin
Thyroglobulin production by thyroid cells is increased by TSH. Two ways of measuring thyroglobulin exist, and they give different information.
Unstimulated thyroglobulin: Measured while on standard levothyroxine therapy with TSH suppressed. This is the routine surveillance test. A detectable value is suspicious, but small amounts of residual normal tissue can produce low levels.
Stimulated thyroglobulin: Measured when TSH is elevated, either by stopping levothyroxine temporarily or by giving recombinant TSH (Thyrogen). Any thyroid cells present produce maximum thyroglobulin, making even very small amounts of residual tissue detectable.
Stimulated thyroglobulin testing is less commonly used today than in the past. Modern thyroglobulin assays are sensitive enough that the unstimulated value provides reliable information in most patients. Stimulated testing is reserved for situations where there is uncertainty about whether very small amounts of disease remain.
What a Rising Thyroglobulin Means
A rising thyroglobulin over consecutive measurements is one of the most reliable signals in thyroid cancer surveillance. The rate of rise (the doubling time) carries prognostic weight. A slow doubling time, measured in years, often reflects indolent disease that may be safely observed. A short doubling time, measured in months, prompts more urgent investigation and treatment.
| Thyroglobulin Pattern | What It Suggests |
|---|---|
| Undetectable, stable | Excellent response. Disease-free. |
| Low detectable, stable | Indeterminate. Often small residual normal tissue. Continue surveillance. |
| Detectable, slowly rising | Possible biochemical recurrence. Imaging recommended to localize source. |
| Detectable, rapidly rising | Active disease likely. Comprehensive imaging and treatment plan needed. |
The Common Frustration: Detectable but Not Localizable
A rising thyroglobulin without an identifiable source on imaging is one of the more frustrating situations in thyroid cancer surveillance. The clinical term is biochemical recurrence with negative imaging. It tells you that cancer cells exist somewhere but does not show where. Options include continued surveillance with repeat imaging at intervals, additional imaging modalities such as a whole-body iodine scan or FDG-PET, and in some cases empiric treatment with radioactive iodine.
⚕ Clinical note: Many patients with a low-but-stable detectable thyroglobulin live for decades with no progression and no clinical disease. A number that is detectable is not the same as a number that is rising. The trend over time is the question that matters.
The Bottom Line
Thyroglobulin is an extremely important surveillance lab for patients who have had total thyroidectomy for differentiated thyroid cancer. It should be measured along with thyroglobulin antibodies at scheduled follow-up visits. The trend over time matters more than any single value. A rising thyroglobulin prompts investigation; an undetectable thyroglobulin is reassuring. The test is not useful after lobectomy alone or for medullary thyroid cancer.
At every surveillance visit, confirm that both thyroglobulin and thyroglobulin antibody were measured together and ask how the result compares to your prior values.
This article is intended for patient education only. It does not constitute medical advice and does not replace a consultation with your physician. Individual patient circumstances and clinical judgment determine the appropriate evaluation and management for every patient.
More from the Thyroid Cancer series
Ready to Talk to a Specialist?
A thyroid specialist can review your specific results, answer your questions, and help you understand exactly what your next steps should be. The ATLAS network connects you with experienced thyroid and parathyroid expert physicians who focus on thyroid disease.
Find a Thyroid Specialist Near You →